Wenbo Hao | Enzyme | Best Research Article Award

Published on by Top Pharmaceutical

Best Research Article Award

Wenbo Hao – Henan Agricultural University, Zhengzhou, China

Wenbo Hao
Affiliation Henan Agricultural University
Country China
Scopus ID 57209716758
Documents 11
Citations 280
h-index 7
Subject Area Enzyme
Event International Top Pharmaceutical Awards
ORCID 0000-0002-2203-0986

Wenbo Hao is a researcher affiliated with Henan Agricultural University in China whose documented research record includes enzyme-based approaches for the degradation and detoxification of mycotoxins, as well as work concerning antimicrobial resistance in animal-associated bacteria. The supplied researcher records identify 11 documents, 280 citations, and an h-index of 7. The available publication information particularly identifies research involving the Lac-W laccase system and its application to multiple mycotoxins. [1] [2]

Abstract

Wenbo Hao’s documented research profile reflects a multidisciplinary research direction centered on enzymes, mycotoxin detoxification, food and feed safety, and microbiological resistance mechanisms. Records supplied from ORCID identify publications involving laccase Lac-W and mycotoxin degradation, including studies published in Toxicon: X and Toxins. The Scopus profile supplied for this article records 11 documents, 280 citations, and an h-index of 7. [1] Collectively, the documented publications provide a research basis for consideration under a research-oriented award category. [3] [4]

Keywords

Wenbo Hao; enzyme; laccase; Lac-W; mycotoxin detoxification; food safety; feed safety; biodegradation; enzymatic detoxification; antimicrobial resistance; pharmaceutical biotechnology; toxin degradation; molecular docking; agricultural biotechnology.

Introduction

Enzyme-based detoxification has attracted research interest because biological catalysts can provide alternative approaches for transforming undesirable chemical contaminants. Within the supplied publication record, Wenbo Hao is associated with studies of Lac-W, a laccase investigated for its capacity to degrade several important mycotoxins. The research includes investigations of mediator-assisted and mediator-free enzymatic systems. [3] [5]

Research Profile

The supplied Scopus profile identifies Wenbo Hao with Henan Agricultural University, Zhengzhou, China, and lists Scopus Author ID 57209716758. The same record reports 11 documents, 280 citations, and an h-index of 7. [1] The profile also indicates a collaborative publication environment involving researchers from Henan Agricultural University and other institutions.

Research Contributions

Wenbo Hao’s research contributions focus on enzyme-based mycotoxin degradation, particularly the application of Lac-W laccase for detoxifying diverse mycotoxins. His work also examines mediator-assisted enzymatic degradation and modified mycotoxins, supporting the development of biological approaches for toxin reduction. His broader research involvement also includes antimicrobial-resistance studies in animal-associated bacteria, extending his contributions across agricultural and biological research. [3]

Publications

Wenbo Hao’s documented publications include research on laccase Lac-W, mycotoxin degradation, enzymatic detoxification, and antimicrobial resistance. His publication record covers studies of fumonisins, aflatoxin B1, deoxynivalenol derivatives, and other major mycotoxins, demonstrating a continuing research interest in enzyme-mediated toxin transformation. The supplied Scopus profile records 11 documents, while the ORCID record identifies published works in Toxicon: X and Toxins. [1] [2]

Research Impact

The supplied Scopus record reports 280 citations and an h-index of 7 for Wenbo Hao, together with 11 indexed documents. [1] These metrics provide quantitative evidence of scholarly visibility within the indexed research record. The publication portfolio also demonstrates collaboration across enzyme science, food and feed safety, toxicology, veterinary science, and antimicrobial resistance. [4]

Award Suitability

The documented research record is potentially relevant to a Best Research Article Award because it contains peer-reviewed research articles addressing defined scientific problems through experimental and analytical methodologies. The publications concerning Lac-W provide a recognizable research theme involving enzymatic degradation and detoxification of mycotoxins, while the antimicrobial-resistance publication demonstrates additional collaborative research activity. [3]

Conclusion

Wenbo Hao’s documented academic profile at Henan Agricultural University includes research in enzyme science, mycotoxin detoxification, food and feed safety, and antimicrobial resistance. The supplied ORCID and Scopus records provide identifiable evidence of publications, institutional affiliation, research output, citations, and author-level metrics. The publication record therefore provides a substantive basis for academic recognition under a research article award category, subject to independent evaluation by the awarding organization.[1] [2]

References

  1. Elsevier. (n.d.). Scopus author details: Wenbo Hao, Author ID 57209716758. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57209716758
  2. ORCID. (n.d.). Wenbo Hao, ORCID iD 0000-0002-2203-0986. ORCID.https://orcid.org/0000-0002-2203-0986
  3. Xu, K., Zhang, D., Geng, C., Wang, X., Harmer, N. J., Yang, J., Zhang, J., Yang, W., & Hao, W. (2025). High-efficiency detoxification of fumonisin B1, B2 and B3 by laccase Lac-W with ABTS. Toxicon: X, 28, 100236.https://doi.org/10.1016/j.toxcx.2025.100236
  4. Jia, M., Yu, X., Xu, K., Gu, X., Harmer, N. J., Zhao, Y., Xiang, Y., Sheng, X., Li, C., Du, X.-D., Pan, J., & Hao, W. (2024). The high-efficiency degradation of multiple mycotoxins by Lac-W laccase in the presence of mediators. Toxins, 16(11), 477.https://doi.org/10.3390/toxins16110477
  5. Geng, C., Wang, X., Zhang, J., et al., & Hao, W. (2026). Detoxification of 3- and 15-acetyldeoxynivalenol and deoxynivalenol-3-glucoside by laccase Lac-W with acetosyringone. Toxicon, 282, 109214.https://doi.org/10.1016/j.toxicon.2026.109214

Bamidele Iwalokun | Immunoinformatics | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

Bamidele Iwalokun — Nigerian Institute of Medical Research, Nigeria

Bamidele Iwalokun
Affiliation Nigerian Institute of Medical Research
Country Nigeria
Scopus ID 57217109793
Documents 92
Citations 1,482
h-index 23
Subject Area Immunoinformatics
Event International Top Pharmaceutical Awards
ORCID 0000-0003-4247-2797

Bamidele Iwalokun is a Nigerian biomedical researcher affiliated with the Nigerian Institute of Medical Research, where the supplied ORCID record identifies his employment as Head of Molecular Biology & Biotechnology. The same record identifies doctoral training in Biochemistry and documents a substantial body of scholarly works spanning molecular biology, infectious diseases, antimicrobial resistance, genomics and computational vaccine research. [1]

Abstract

Bamidele Iwalokun’s documented research profile encompasses molecular biology, biotechnology, infectious disease research, antimicrobial resistance, genomics and immunoinformatics. His publication record includes computational investigations of vaccine candidates and mRNA vaccine design, alongside laboratory and epidemiological studies of infectious diseases. The ORCID record supplied for this article documents multiple recent publications with established journal and DOI information. [2] [3]

Keywords

Immunoinformatics; vaccine design; mRNA vaccines; epitope-based vaccines; molecular biology; biotechnology; infectious diseases; antimicrobial resistance; genomics; computational biology; pharmaceutical research; vaccine development; biomedical innovation.

Introduction

Immunoinformatics applies computational methods to immunological data and is increasingly used to support the identification and evaluation of vaccine targets, epitopes and antigenic features. Such approaches can help organize complex biological information before experimental validation and may contribute to more systematic vaccine-development workflows. Iwalokun’s documented publications include several studies explicitly describing immunoinformatics-based approaches to vaccine design. [2]

Research Profile

His documented research profile intersects molecular biology, biotechnology, infectious disease microbiology and computational approaches to vaccine development. In particular, publications from 2024 describe immunoinformatics applications to Mokola virus, vaccinia and Mpox viruses, Epstein–Barr virus and hepatitis E virus. These works provide direct evidence for the relevance of immunoinformatics within his broader research portfolio. [2]

Research Contributions

The wider publication record includes research on multidrug-resistant organisms, resistance-associated genes, whole-genome sequencing and pathogen characterization. Examples include studies of methicillin-resistant Staphylococcus aureus, carbapenemase-producing Pseudomonas aeruginosa, multidrug-resistant Escherichia coli and molecular characteristics of other clinically important organisms. These investigations complement the computational research by addressing biological and microbiological questions relevant to infectious disease control. [5] [6]

Publications

The supplied ORCID record lists numerous scholarly works associated with Bamidele Iwalokun. Recent publications include research on infection prevention and control among healthcare workers in Nigerian COVID-19 treatment centres, the molecular landscape of methicillin-resistant Staphylococcus aureus, and computational vaccine-related studies. The record also identifies DOI information for these publications, providing persistent identifiers for scholarly verification.[4]

Research Impact

Beyond bibliometric indicators, the research record demonstrates activity across several interconnected biomedical themes. The combination of computational vaccine design, molecular characterization, antimicrobial resistance research and infectious disease studies provides a multidisciplinary foundation. This breadth may be particularly relevant to research recognition programs that consider methodological innovation and contribution to pharmaceutical or biomedical science. [1] [2]

Award Suitability

The documented research profile is substantively aligned with an Innovative Research Award because it contains peer-reviewed work applying computational and molecular approaches to contemporary vaccine-development questions. The immunoinformatics publications provide direct evidence of innovation-oriented research activity, particularly through computational vaccine design and epitope-based strategies. [4]

Conclusion

Bamidele Iwalokun’s documented scholarly profile represents a multidisciplinary research portfolio spanning molecular biology, biotechnology, infectious diseases, antimicrobial resistance and immunoinformatics. The combination of computational vaccine research and molecular infectious disease research provides a strong scholarly basis for considering the profile in the context of innovative pharmaceutical and biomedical research. The available publication evidence supports a neutral assessment of substantial research activity in areas that intersect immunoinformatics, vaccine development and translational biomedical science.[4]

References

  1. ORCID. (2026). Bamidele Iwalokun — ORCID record. ORCID.
    https://orcid.org/0000-0003-4247-2797
  2. Oladipo, E. K., Ogunniran, J. A., Akinpelu, O. S., Omole, T. O., Adeyemo, S. F., Irewolede, B. A., Iwalokun, B. A., Ajani, O. F., & Onyeaka, H. (2024). Bioinformatics designing of an mRNA vaccine for Mokola virus (MOKV) using immunoinformatics as a secure strategy for successful vaccine development. BMC Immunology.
    https://doi.org/10.1186/s12865-024-00668-2
  3. Oladipo, E. K., Oyelakin, O. D., Aiyelabegan, A. O., Olajide, E. O., Olatayo, V. O., Owolabi, K. P., Shittu, Y. B., Olugbodi, R. O., Ajala, H. A., et al. (2024). Exploring computational approaches to design mRNA vaccine against vaccinia and Mpox viruses. Immunity, Inflammation and Disease.
    https://doi.org/10.1002/iid3.1360
  4. Oladipo, E. K., Dairo, E. O., Bamigboye, C. O., Ajayi, A. F., Onile, O. S., Ariyo, O. E., Jimah, E. M., Oyawoye, O. M., Oloke, J. K., Iwalokun, B. A., et al. (2024). Harnessing immunoinformatics for precision vaccines: Designing epitope-based subunit vaccines against hepatitis E virus. BioMedInformatics, 4(3), 88.
    https://doi.org/10.3390/biomedinformatics4030088
  5. Olalekan, A., Bader, B. K., Iwalokun, B., Wolf, S., Lalremruata, A., Dike, A., Mannie-Udoh, M., Lo Presti, L., Liese, J., Guther, J., et al. (2023). High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria. JAC-Antimicrobial Resistance.
    https://doi.org/10.1093/jacamr/dlad038

Ketan Ruparelia | Cancer Research | Research Excellence Award

Published on by Top Pharmaceutical

Research Excellence Award

Ketan Ruparelia — De Montfort University, United Kingdom

Ketan Ruparelia
Affiliation De Montfort University
Country United Kingdom
Scopus ID 6506888701
Documents 39
Citations 1,939
h-index 20
Subject Area Cancer Research
Event International Top Pharmaceutical Awards
ORCID 0000-0002-4091-2878

Ketan Ruparelia is a researcher affiliated with De Montfort University in Leicester, United Kingdom. His documented research works include studies spanning pharmaceutical and cancer-related research, including drug-delivery systems, anticancer compounds, phytochemical analysis, and medicinal chemistry. The available research record provides evidence of publications involving chemotherapy-related nanocarriers, synthetic resveratrol analogues, plant secondary metabolism, and flavone-based enzyme inhibition. These works provide a scholarly basis for considering his profile within pharmaceutical research and cancer-focused scientific activity. [1]

Abstract

Ketan Ruparelia’s documented research profile is associated with pharmaceutical and biomedical research, with particular relevance to cancer research, drug delivery, phytochemical investigation, and anticancer compound development. The available ORCID record lists five research works and identifies De Montfort University as his employment affiliation. [1]

Keywords

Ketan Ruparelia, pharmaceutical research, cancer research, drug delivery, nanomedicine, siRNA delivery, multidrug-resistant cancer, chemotherapy, mesoporous silica nanoparticles, anticancer compounds, resveratrol analogues, medicinal chemistry, phytochemical analysis, plant secondary metabolism, flavones, tyrosinase inhibitors, pharmaceutical biotechnology, International Top Pharmaceutical Awards.

Introduction

Pharmaceutical research increasingly combines medicinal chemistry, drug-delivery engineering, molecular biology, and natural-product investigation to address complex therapeutic challenges. Ruparelia’s documented works intersect several of these areas, particularly through research involving anticancer compounds and pharmaceutical delivery technologies. [1][3]

Research Profile

The ORCID record identifies Ketan Ruparelia and associates the profile with De Montfort University in Leicester, Leicestershire, United Kingdom. The employment entry specifies the position of Senior Technician in Health & Life Sciences, while the record also lists five works with Crossref-linked publication information. The supplied bibliometric profile reports 39 documents, 1,939 citations, and an h-index of 20, with Cancer Research identified as the principal subject area. [1]

Research Contributions

A central contribution documented in the available record concerns pharmaceutical nanotechnology and targeted nucleic-acid delivery. The 2025 European Journal of Pharmaceutics and Biopharmaceutics article examines electrosprayed core-shell polyethyleneimine and phospholipid-coated mesoporous silica nanoparticles for co-delivery of KAZ3 and MDR-1 siRNA. [1]

Publications

Ketan Ruparelia’s publications span pharmaceutical nanotechnology, cancer research, medicinal chemistry, and phytochemical analysis. His 2025 article on electrosprayed core-shell nanoparticles investigated KAZ3 and MDR-1 siRNA co-delivery for chemotherapy in multidrug-resistant colon cancer. [1] His other works examine synthetic resveratrol analogues, indanone-based chalcone analogues, plant secondary metabolism, and flavone tyrosinase inhibition. [2]

Research Impact

The reported bibliometric profile indicates 39 documents, 1,939 citations, and an h-index of 20. These figures provide quantitative indicators of scholarly visibility within the supplied profile, while the underlying publication record demonstrates activity across pharmaceutical delivery, cancer research, medicinal chemistry, and phytochemical investigation. In particular, nanoparticle-mediated siRNA delivery connects pharmaceutical formulation with cancer biology, whereas resveratrol analogue research links synthetic chemistry with anticancer investigation. [1][3]

Award Suitability

The documented research profile is relevant to a Research Excellence Award within a pharmaceutical research context because it encompasses multiple areas directly connected with drug development and cancer-oriented pharmaceutical science. The evidence includes peer-reviewed journal articles, DOI-indexed works, and research involving drug-delivery systems and anticancer compounds. [1][3]

Conclusion

Ketan Ruparelia’s documented research profile reflects interdisciplinary activity relevant to pharmaceutical and cancer research. His recorded works encompass nanocarrier-based siRNA delivery, anticancer resveratrol analogues, synthetic chemistry, phytochemical analysis, and enzyme-inhibitor research. The combination of these research areas provides a substantive scholarly basis for recognition under a pharmaceutical research excellence category.[1][3]

References

  1. Sayed, E., Ruparelia, K., Zafar, S., Faheem, A., Fatouros, D., Arshad, M. S., Singh, N., & Ahmad, Z. (2025). Novel electrosprayed core-shell polyethyleneimine and phospholipid coated MSNs for Co-delivery of KAZ3 and MDR-1 siRNA for efficient chemotherapy in multidrug-resistant colon cancer. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114838
  2. Pal, P., Ruparelia, K. C., Arroo, R. R. J., & Brucoli, F. C. (2025). A Green Chemistry Approach for the Synthesis of Indanones as Fixed Ring Chalcone Analogues. Preprints. https://www.preprints.org/manuscript/202504.1089
  3. Ruparelia, K. C., Zeka, K., Beresford, K. J. M., Wilsher, N. E., Potter, G. A., Androutsopoulos, V. P., Brucoli, F., & Arroo, R. R. J. (2024). CYP1-Activation and Anticancer Properties of Synthetic Methoxylated Resveratrol Analogues. Molecules, 29(2). https://doi.org/10.3390/molecules29020423
  4. Arroo, R. R. J., Bhambra, A. S., Hano, C., Renda, G., Ruparelia, K. C., & Wang, M. F. (2021). Analysis of plant secondary metabolism using stable isotope-labelled precursors. Phytochemical Analysis. https://doi.org/10.1002/pca.2955
  5. Arroo, R. R. J., Sari, S., Barut, B., Özel, A., Ruparelia, K. C., & Şöhretoğlu, D. (2020). Flavones as tyrosinase inhibitors: kinetic studies in vitro and in silico. Phytochemical Analysis. https://doi.org/10.1002/pca.2897

Ruth Etiosa Olusola | Medicinal Chemistry | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Ruth Etiosa Olusola 
Caleb University, Nigeria

Ruth Etiosa Olusola
Affiliation Caleb University
Country Nigeria
Scopus ID 59166859900
Documents 9
Citations 251
h-index 4
Subject Area Medicinal Chemistry
Event International Top Pharmaceutical Awards
Google Scholar 5PU6WugAAAAJ

Ruth Etiosa Olusola (Nee Ogbemudia) is a researcher affiliated with Caleb University, Imota, Nigeria, whose documented scholarly interests include organic chemistry, natural product chemistry, organic synthesis, plant bio-assay and heavy-metal analysis. Her research record includes studies of plant-derived constituents, phytochemical profiling, nutritional composition, antimicrobial activity and analytical approaches relevant to pharmaceutical and natural-product research. Her Google Scholar profile records 251 citations and an h-index of 4, providing a measurable basis for considering her research profile within the scope of the Best Researcher Award. [1]

Abstract

Ruth Etiosa Olusola is a Nigerian researcher whose academic profile combines organic chemistry and natural-product research with analytical and bioassay-oriented investigations. The available scholarly record identifies Caleb University, Imota, as her institutional affiliation and lists organic chemistry, natural product chemistry, organic synthesis, plant bio-assay and heavy-metal analysis among her research areas. [1] Her publication record includes work on soybean composition, phytochemical characterization of Aspilia africana, chitosan-based heavy-metal adsorption and investigations of Spilanthes filicaulis. [2] These studies collectively demonstrate an interdisciplinary research profile connecting chemistry, natural products, analytical science and pharmaceutical research.

Keywords

Ruth Etiosa Olusola, Best Researcher Award, Medicinal Chemistry, Organic Chemistry, Natural Product Chemistry, Organic Synthesis, Plant Bio-assay, Phytochemical Analysis, GC-MS, Antimicrobial Research, Pharmaceutical Research, Natural Products, Heavy Metal Analysis, Chitosan Adsorption, Spilanthes filicaulis, Aspilia africana, International Top Pharmaceutical Awards.

Introduction

Natural-product and medicinal-chemistry research provides an important scientific pathway for investigating biologically active compounds and chemically characterizing materials derived from plants and other natural sources. Olusola’s documented work fits within this broad research landscape through studies involving phytochemical screening, GC-MS analysis, antimicrobial investigation and computational assessment of plant-derived compounds. [3] Her research also extends into analytical chemistry through mineral and proximate composition studies and investigations of heavy-metal removal using modified chitosan materials. [4]

Research Profile

The research profile documented for Olusola identifies Organic Chemistry and Natural Product Chemistry as central areas, alongside Organic Synthesis, Plant Bio-assay and Heavy Metal Analysis. [1] Her publications show practical application of these areas through chemical extraction, phytochemical screening, chromatographic analysis and biological evaluation. In particular, her work on Aspilia africana used phytochemical studies and GC-MS analysis to characterize compounds present in chloroform leaf extracts. [2]

Research Contributions

A significant contribution of the documented research is the investigation of plant materials as sources of phytochemicals and potentially useful bioactive compounds. Research involving Spilanthes filicaulis has examined its ethnopharmacological importance and summarized available evidence concerning its chemical and pharmacological characteristics. [5] A subsequent 2026 study involving Olusola investigated antimicrobial effects, phytochemical profiling and in-silico analysis of compounds from the plant, thereby connecting experimental biological testing with computational drug-development approaches.

Publications

The available profile lists nine documents published between 2016 and 2026, covering plant chemistry, nutritional composition, adsorption materials, and pharmacological research. The publications demonstrate a multidisciplinary research profile spanning natural products, analytical chemistry, and pharmaceutical-related investigations. [1] Several of the listed studies have identifiable DOI records, providing persistent links for independent access to the corresponding scholarly publications.

Research Impact

The available Google Scholar record reports 251 citations and an h-index of 4, indicating that the documented publications have received measurable scholarly attention. [1] The profile also records an i10-index of 2. Her highly cited work on soybean composition demonstrates substantial visibility within the listed record, while her more recent work on Spilanthes filicaulis extends the research portfolio toward antimicrobial activity, phytochemical profiling and computational analysis[3]

Award Suitability

The documented combination of publication activity, citation impact and interdisciplinary chemistry research provides a reasonable academic basis for consideration for a Best Researcher Award. Her work connects organic and natural-product chemistry with phytochemical characterization, plant bio-assay, analytical investigation and research relevant to pharmaceutical discovery. The 2026 study integrating antimicrobial assays, phytochemical profiling and in-silico analysis further demonstrates a contemporary research direction that links natural products with potential drug-development investigations. [3]

Conclusion

Ruth Etiosa Olusola represents a chemistry-focused research profile with documented activity in organic chemistry, natural products, phytochemical analysis, plant bio-assay and analytical research. Her publication record includes studies of medicinal plants, nutritional composition, antimicrobial properties and adsorption materials. The available citation indicators, together with her continuing publication activity, provide relevant evidence for academic recognition under a Best Researcher Award framework. [1]

References

    1. Google Scholar. (n.d.). Ruth Etiosa Olusola (Nee Ogbemudia), author profile. Google Scholar. Citation and bibliographic information accessed from the supplied researcher profile.https://scholar.google.com/citations?user=5PU6WugAAAAJ&hl=en
    2. Ogbemudia, R. E., Adeyemo, J. A., & Nwadozie, B. C. (2018). Phytochemical Studies and GC-MS Analysis of Chloroform Extract of the Leaves of Aspilia africana. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2017/38663
    3. Ojo, O., Olusola, R. E., & Ojo, O. O. (2024). Spilanthes filicaulis (Schumach. & Thonn.) C. D. Adams: An insights into ethnopharmacologically important but scientifically understudied species. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2024.05.010
    4. Olohigbe, A. B., Ogbemudia, R. E., & Okiei, W. (2018). Highly Deacetylated Chitosan as Low-cost Adsorbent Material for Removal of Heavy Metals from Water. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2018/38599
    5. Ogbemudia, R. E., Nnadozie, B. C., & Anuge, B. (2018). Mineral and Proximate Composition of Soya Bean. Asian Journal of Physical and Chemical Sciences. https://doi.org/10.9734/AJOPACS/2017/38530

Onwu Daniel Ocha | Drug Discovery | Best Researcher Award

Published on by Top Pharmaceutical

Best Researcher Award

Onwu, Daniel Ocha
Affiliation University of Cross River State
Country Nigeria
Google Scholar ID n6jcvPsAAAAJ
Documents 9
Citations 2
h-index 1
Subject Area Drug Discovery
Event International Top Pharmaceutical Awards

Onwu Daniel Ocha – University of Cross River State

Onwu Daniel Ocha is a researcher affiliated with the University of Cross River State (UNICROSS), Calabar, Nigeria. His reported scholarly work is associated with computational biology, bioinformatics, drug discovery, network pharmacology, phytochemical investigation, and computational modelling. The supplied Google Scholar record reports nine documents, two citations, and an h-index of one. The profile also identifies computational biology and bioinformatics among the research areas associated with his scholarly activity.

Abstract

Onwu Daniel Ocha’s research profile reflects interdisciplinary activity connecting computational biology and bioinformatics with pharmaceutical and biomedical investigation. His available publication record includes research on phytochemicals, network pharmacology, computational modelling, biological targets, infectious diseases, and therapeutic investigation. These subjects are relevant to modern drug discovery because computational approaches can support the identification of candidate compounds, molecular targets, pathways, and potential mechanisms of action. His research record therefore demonstrates an emerging connection between computational science and pharmaceutical research. [1]

Keywords

Drug Discovery; Computational Biology; Bioinformatics; Network Pharmacology; Computational Modelling; Molecular Docking; Phytochemicals; Drug Target Identification; Systems Biology; Therapeutic Targeting; Pharmaceutical Research; In-silico Research; Biomedical Informatics.

Introduction

Computational biology and bioinformatics have become important components of modern pharmaceutical research. Computational approaches can be used to examine molecular interactions, biological pathways, disease-associated targets, and candidate therapeutic compounds before or alongside laboratory validation. Network pharmacology is particularly useful for studying complex relationships between compounds, proteins, pathways, and disease mechanisms. These approaches can contribute to the prioritization of potential therapeutic candidates and provide hypotheses for subsequent experimental research [1].

Research Profile

The supplied academic profile identifies Onwu Daniel Ocha with the University of Cross River State (UNICROSS), Calabar, Nigeria. His Google Scholar record reports nine documents, two citations, and an h-index of one. The research areas represented in the supplied profile include computational biology and bioinformatics, while the award profile specifically identifies Drug Discovery as the subject area. This combination places his research at the intersection of computational science and pharmaceutical investigation.[3]

Research Contributions

A notable contribution in the supplied publication record is the study titled In-Silico and Network Pharmacology Analysis of Mimosa invisa Phytochemicals against Testicular Inflammation. The work examines phytochemical compounds using computational approaches to investigate their potential relationships with inflammation-associated biological targets. This research direction is relevant to drug discovery because phytochemicals may provide candidate structures for further pharmacological investigation [3].

Publications

The available publication record demonstrates continuing scholarly activity in computational and biomedical research. Listed publications include studies on Mimosa invisa phytochemicals, biosynthesized silver nanoparticles, Terminalia catappa extracts, Allium cepa bioactive compounds, drug-resistant tuberculosis, Tefairia occidentalis phytocompounds, and computational analysis of antiviral targets. The diversity of these topics indicates an interdisciplinary research approach involving computational methods and biological investigation.[3].

Research Impact

The supplied Google Scholar profile reports two citations and an h-index of one. These bibliometric indicators represent the citation activity recorded by the profile at the time of the supplied document and may change as additional publications are indexed and cited. Therefore, citation indicators should be considered together with publication quality, research relevance, collaboration, and scientific contribution when assessing an emerging researcher.[4].

Award Suitability

The award assessment should nevertheless remain evidence-based and should consider the complete research portfolio, verified publication records, originality, methodological quality, scholarly contribution, collaboration, and the official eligibility criteria established by the award organizers. The available profile demonstrates an emerging publication record rather than providing sufficient evidence for unsupported claims of exceptional impact. This distinction maintains a neutral academic approach to recognition[4].

Conclusion

Onwu Daniel Ocha’s documented research profile demonstrates interdisciplinary activity involving computational biology, bioinformatics, drug discovery, network pharmacology, phytochemicals, and systems biology. The supplied record identifies nine documents, two citations, and an h-index of one, while the listed publications demonstrate research activity across several biomedical and pharmaceutical themes. [1].

References

  1. Onwu, D. O., Uraku, O. H., Agbi, M. T., & Uraku, A. J. (2026). In-silico and network pharmacology analysis of Mimosa invisa phytochemicals against testicular inflammation. In Silico Research in Biomedicine, 2, 100274.
    https://doi.org/10.1016/j.insi.2026.100274
  2. Onwu, D., Edun, S., Asuquo, U., & Bajepade, T. I. (2025). Antidiabetic potential of biosynthesized silver nanoparticles with fresh guava leaf. Covenant Journal of Physical and Life Sciences, 13(2), 1–6.
    https://journals.covenantuniversity.edu.ng/index.php/cjpls/article/view/4978
  3. Onwu, D. O., Kayode, D., Oluwatosin, C. E., Chimaobi, N. G., Johnson, O., et al. (2026). Assessing the effects of aqueous extract of Terminalia catappa on immunoglobulins levels in cyclophosphamide induced immunosuppressant Wistar rats. Next Research, 101441.
    https://doi.org/10.1016/j.nexres.2026.101441
  4. Onwu, D. O., Singh, A., Bajpai, Y., Akinlamilo, A. S., Habiganuchi, A., & Ibikunle, F. O. (2025). Host–pathogen interaction mapping in drug-resistant tuberculosis: A systems biology framework for dual therapeutic targeting. Research Square.
    https://doi.org/10.21203/rs.3.rs-7855974/v1
  5. Ahmad, A., Nnenna, A. O., Mamman, S., Nwokoro, C., Bello, A. M., Nseabasi, M. A., Abdulwakiil, M., Okpe, J., Onwu, D. O., Agbi, M., & Idoko, A. (2025). In-silico network pharmacology and computational modelling of bioactive compounds from Allium cepa targeting downstream protein effectors in diabetes. Research Square.
    https://doi.org/10.21203/rs.3.rs-8181479/v1

Manjula M Venkatappa | Nanotechnology | Young Scientist Award

Published on by Top Pharmaceutical

 

Young Scientist Award

Manjula M Venkatappa
Affiliation Saint Louis University
Country India
Google Scholar ID UHqSN-oAAAAJ
Documents 27
Citations 408
h-index 11
Subject Area Nanotechnology
Event International Top Pharmaceutical Awards
Scopus 57443895000

Manjula M Venkatappa – Saint Louis University

Manjula M Venkatappa is a researcher whose reported scholarly work is associated with nanotechnology, biochemistry, oxidative-stress biology, natural products, and biologically synthesized nanoparticles. Her publication record includes studies investigating metal and metal-oxide nanoparticles and their potential biological activities. Several publications have examined antioxidant, anti-inflammatory, antithrombotic, and related pharmacological effects in experimental models. These research themes provide a relevant scientific basis for consideration within a pharmaceutical research recognition framework.

Abstract

Manjula M Venkatappa’s research profile reflects interdisciplinary activity connecting nanotechnology with biomedical and pharmaceutical science. Her publications include investigations of green-synthesized magnesium oxide, titanium dioxide, cobalt ferrite, copper ferrite, and zinc ferrite nanoparticles. These studies have considered nanoparticle characterization together with biological outcomes such as oxidative stress modulation, inflammation, thrombosis, and cancer-cell responses. Such work illustrates the potential role of nanotechnology-enabled approaches in pharmaceutical and biomedical research.

Keywords

Nanotechnology; Nanoparticles; Green Synthesis; Nanomedicine; Oxidative Stress; Antioxidant Activity; Anti-inflammatory Activity; Antithrombotic Research; Cancer Biology; Biochemistry; Natural Products; Pharmaceutical Research; Biomedical Nanotechnology.

Introduction

Nanotechnology has become an important research area in pharmaceutical and biomedical sciences because nanoscale materials can provide distinctive physicochemical and biological properties. Green synthesis approaches are particularly relevant where researchers seek to use biological materials as reducing, stabilizing, or capping agents. Venkatappa’s published studies have explored this research direction through plant-mediated synthesis and evaluation of several nanoparticle systems. Her work therefore contributes to a broader scientific discussion concerning nanomaterials and their possible biomedical applications [1].

Research Profile

The reported profile combines nanotechnology with experimental biochemistry and biological evaluation. A notable component of the publication record involves green-fabricated nanoparticles produced using botanical extracts and subsequently evaluated using biochemical or cellular models. Research has included magnesium oxide, titanium dioxide, cobalt ferrite, copper ferrite, and zinc ferrite nanoparticle systems. The studies indicate an interest in linking material synthesis and characterization with measurable biological effects [2].

Research Contributions

One contribution concerns the investigation of biofunctional magnesium oxide nanoparticles produced through green synthesis. The study evaluated oxidative-stress-induced tissue damage and thrombosis, providing a biological framework for examining the activity of nanoscale materials [1]. Another publication investigated green-synthesized titanium dioxide nanoparticles and their relationships with oxidative stress, inflammation, and human breast cancer proliferation [2]. Together, these studies demonstrate a consistent interest in biologically relevant nanoparticle systems.

Publications

Selected publications associated with Manjula M Venkatappa demonstrate a progression from nanoparticle synthesis and characterization toward biological and pharmacological evaluation. The publication record includes peer-reviewed articles addressing metal-oxide and ferrite nanoparticles, oxidative stress, inflammation, thrombosis, and cancer-related biological responses. DOI identifiers provide persistent links to the corresponding scholarly records. These publications form an appropriate evidence base for evaluating the researcher’s contribution to nanotechnology-oriented pharmaceutical research.

Research Impact

The reported scholarly indicators of 408 citations and an h-index of 11 suggest measurable academic visibility for the supplied research profile. Citation counts and h-index values can change over time and should therefore be interpreted as dynamic bibliometric indicators rather than permanent measures of research quality. The publications themselves provide additional evidence of interdisciplinary engagement across nanotechnology, biochemistry, and biomedical investigation. This combination is relevant to pharmaceutical research areas concerned with nanoscale materials and biological activity.

Award Suitability

The research profile is potentially suitable for consideration for the Young Scientist Award under the International Top Pharmaceutical Awards because its documented publication themes intersect with pharmaceutical nanotechnology and biomedical applications. The evidence includes peer-reviewed studies on green-synthesized nanoparticles and their experimentally evaluated biological activities. In particular, research involving oxidative stress, inflammation, thrombosis, and cancer-related responses provides clear connections to pharmaceutical and therapeutic research. Final award decisions should be based on the organizers’ eligibility requirements, verified bibliometric records, originality, scientific quality, and the complete submitted research portfolio.

Conclusion

Manjula M Venkatappa’s reported research portfolio demonstrates an interdisciplinary focus on nanotechnology and biological applications. Her publications cover multiple nanoparticle platforms and investigate experimentally relevant outcomes involving oxidative stress, inflammation, thrombosis, and cancer biology. The combination of nanomaterial development and biological evaluation is closely aligned with emerging pharmaceutical nanotechnology research. On the supplied evidence, the profile represents a relevant candidate for scholarly recognition within a pharmaceutical research award framework.

References

  1. Google Scholar. (n.d.). Manjula M Venkatappa: Google Scholar profile.
    https://scholar.google.com/citations?user=UHqSN-oAAAAJ&hl=en
  2. Venkatappa, M. M., Udagani, C., Hanume Gowda, S. M., Venkataramaiah, S., et al. (2023). Green synthesised TiO2 nanoparticles-mediated Terenna asiatica: Evaluation of their role in reducing oxidative stress, inflammation and human breast cancer proliferation. Molecules, 28(13), 5126.
    https://doi.org/10.3390/molecules28135126
  3. Venkatappa, M. M., Udagani, C., Hanumegowda, S. M., Pramod, S. N., et al. (2022). Effect of biofunctional green synthesized MgO-nanoparticles on oxidative-stress-induced tissue damage and thrombosis. Molecules, 27(16), 5162.
    https://doi.org/10.3390/molecules27165162
  4. Venkataramaiah, S., Venkatappa, M. M., Udagani, C., & Sannaningaiah, D. (2024). Green-synthesized cobalt ferrite nanoparticle alleviated sodium nitrite-induced oxidative stress through its anti-oxidant property and displayed anti-inflammatory, anti-diabetic and anti-platelet activities. Journal of Superconductivity and Novel Magnetism, 37(11), 1839–1857.
    https://doi.org/10.1007/s10948-024-06813-7
  5. Venkataramaiah, S., Venkatappa, M. M., Rangappa, R., Udagani, C., et al. (2025). Green fabricated bimetallic zinc ferrite nanoparticles mitigate oxidative stress-induced pathogenesis. Analytical Biochemistry, 700, 115767.
    https://doi.org/10.1016/j.ab.2025.115767

Shalini Singh | Clinical Pharmacology | Women Researcher Award

Published on by Top Pharmaceutical

Women Researcher Award

Shalini Singh
Global Cosmetic Regulatory Services Pvt Ltd, India

Shalini Singh
Affiliation Global Cosmetic Regulatory Services Pvt Ltd
Country India
Google Scholar N3KRvykAAAAJ
Documents 41
Citations 159
h-index 7
Subject Area Clinical Pharmacology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-3743-8888

Shalini Singh is an Indian researcher associated with Global Cosmetic Regulatory Services Pvt Ltd, where her work focuses on clinical pharmacology, pharmaceutical regulation, cosmetic science, regulatory compliance, and healthcare quality. Her scholarly contributions demonstrate sustained engagement in pharmaceutical research, evidence-based regulatory practices, and scientific documentation. Through peer-reviewed publications and collaborative investigations, she has contributed to improving regulatory understanding and pharmaceutical safety within both academic and industrial environments.[1] Her research profile reflects interdisciplinary expertise spanning clinical pharmacology, pharmaceutical sciences, cosmetic regulation, and healthcare innovation.[2]

Abstract

Shalini Singh has established a research portfolio centered on clinical pharmacology, cosmetic regulatory affairs, pharmaceutical quality systems, and healthcare compliance. Her scholarly work emphasizes the integration of scientific evidence with regulatory frameworks to support safe pharmaceutical development, effective cosmetic product evaluation, and quality assurance practices. Through published research and professional collaborations, she has contributed to advancing regulatory science while promoting responsible innovation across pharmaceutical and cosmetic industries. Her publication record, citation profile, and continued academic engagement indicate consistent participation in multidisciplinary pharmaceutical research.[1][3]

Keywords

Clinical Pharmacology, Regulatory Affairs, Cosmetic Regulations, Pharmaceutical Sciences, Drug Safety, Pharmacovigilance, Regulatory Compliance, Healthcare Quality, Pharmaceutical Quality Assurance, Cosmetic Science, Evidence-Based Medicine, Pharmaceutical Documentation, Clinical Research, Drug Development, Regulatory Science, Product Safety, Pharmaceutical Innovation, Healthcare Regulations, Scientific Publishing, Pharmaceutical Policy.

Introduction

Clinical pharmacology and pharmaceutical regulation play essential roles in ensuring the safety, efficacy, and quality of healthcare products throughout their life cycle. Researchers working in these fields contribute to scientific advancement by strengthening regulatory systems, supporting evidence-based decision-making, and improving public health outcomes. Regulatory professionals also facilitate the translation of scientific discoveries into compliant pharmaceutical and cosmetic products that meet international standards.[2]

Research Profile

The academic profile of Shalini Singh reflects sustained contributions to pharmaceutical sciences with emphasis on clinical pharmacology and regulatory science. Her scholarly metrics include forty-one indexed publications, one hundred fifty-nine citations, and an h-index of seven, indicating continued academic visibility and citation impact within her research community.[1]

Research Contributions

Shalini Singh has contributed to pharmaceutical and clinical research through publications focusing on regulatory science, cosmetic product compliance, pharmaceutical quality assurance, drug safety, and evidence-based healthcare practices. Her research supports the development of scientifically validated regulatory frameworks while encouraging harmonization between pharmaceutical innovation and international compliance standards.[2][3]

Publications

The publication portfolio of Shalini Singh demonstrates continuous scholarly activity within pharmaceutical sciences and clinical pharmacology. Her research output includes peer-reviewed articles addressing regulatory science, pharmaceutical development, healthcare quality, cosmetic regulations, and related multidisciplinary areas. Collectively, these publications have contributed to academic discussions concerning pharmaceutical quality assurance and regulatory compliance.[1]

Research Impact

The measurable research impact of Shalini Singh is reflected through publication productivity, citation performance, and continuing engagement with pharmaceutical and regulatory research communities. Her work contributes to scientific understanding of clinical pharmacology, pharmaceutical quality systems, cosmetic regulation, and healthcare policy. Citation indicators demonstrate that her publications have been referenced by subsequent investigations, supporting ongoing knowledge development within pharmaceutical sciences.[1][2]

Award Suitability

Based on her documented publication record, research activity, citation profile, and professional engagement within clinical pharmacology and pharmaceutical regulation, Shalini Singh demonstrates characteristics commonly associated with recognition under the Women Researcher Award presented at the International Top Pharmaceutical Awards. Her contributions illustrate sustained scholarly participation, interdisciplinary collaboration, and commitment to advancing pharmaceutical sciences through research and regulatory excellence.[1][3]

Conclusion

Shalini Singh has established a professional research profile that combines clinical pharmacology, pharmaceutical regulation, cosmetic compliance, and healthcare quality assurance. Through consistent scholarly publications, interdisciplinary collaboration, and evidence-based regulatory research, she contributes to the advancement of pharmaceutical sciences and responsible healthcare innovation. Her academic achievements, publication metrics, and continuing scientific engagement provide a strong foundation for professional recognition within international pharmaceutical research communities.[1][4]

References

  1. Google Scholar. (n.d.). Shalini Singh – Google Scholar Profile. https://scholar.google.com/citations?user=N3KRvykAAAAJ
  2. Singh, S., Arya, V., Mishra, R. K., & Rajput, S. K. (2026). Clinical Effectiveness of Naturopathic Therapeutic Approaches in the Management of Polycystic Ovary Syndrome: Real-World Evidence. Current Indian Science. Advance online publication. https://doi.org/10.2174/012210299X481816260630115057
  3. Singh, S., Arya, V., Mishra, R. K., Rajput, S. K., Mishra, S., & Rana, M. (2025). Mechanistic and Phytopharmacological Insights into Ayurvedic Botanicals for the Management of Polycystic Ovarian Syndrome. Journal of Ayurvedic and Herbal Medicine. https://doi.org/10.4103/JAHM.JAHM_55_25
  4. Singh, S., Arya, V., Mishra, R. K., Rajput, S. K., & Dhanasekaran, M. (2024). Nanotechnology in the diagnosis and management of polycystic ovary syndrome: A systematic scoping analysis to improve patient care. Next Research. https://doi.org/10.1016/j.nexres.2024.100004
  5. Balkrishna, A., Rana, M., Mishra, S., Srivastava, D., Bhardwaj, R., Singh, S., Rajput, S. K., Arya, V., & Rigano, D. (2023). Incredible Combination of Lifestyle Modification and Herbal Remedies for Polycystic Ovarian Syndrome Management. Evidence-Based Complementary and Alternative Medicine. 
    https://doi.org/10.1155/2023/3705508

Sudeep Nagaraj | Virology | Excellence in Research Award

Published on by Top Pharmaceutical

Excellence in Research Award

Sudeep Nagaraj
ICAR-NIVEDI

Sudeep Nagaraj
Affiliation ICAR-NIVEDI
Country India
Scopus ID 58639369200
Documents 10
Citations 81
h-index 5
Subject Area Virology
Event International Top Pharmaceutical Awards
ORCID 0000-0002-0319-6710

Sudeep Nagaraj is a researcher affiliated with ICAR-National Institute of Veterinary Epidemiology and Disease Informatics (ICAR-NIVEDI), India. His academic work primarily focuses on virology, molecular diagnostics, veterinary infectious diseases, epidemiology, and disease surveillance. Through contributions published in internationally indexed journals, his research supports scientific understanding of viral diseases affecting animal health while strengthening diagnostic methodologies and surveillance systems. According to publicly available bibliometric indicators, the researcher has authored multiple Scopus-indexed publications, accumulated measurable citation impact, and maintained continued scholarly engagement within the field of virology.[1]

Abstract

The Excellence in Research Award recognizes sustained scholarly achievement, scientific innovation, and measurable research impact within a specialized academic discipline. Sudeep Nagaraj has contributed to veterinary virology through research involving viral pathogen detection, molecular epidemiology, laboratory diagnostics, and infectious disease surveillance. His publications reflect collaborative scientific efforts aimed at improving disease monitoring, diagnostic accuracy, and evidence-based veterinary health management. Bibliometric indicators demonstrate a growing research influence through indexed publications, citation performance, and continued academic engagement within internationally recognized databases.[1][2]

Keywords

Excellence in Research Award, Sudeep Nagaraj, Veterinary Virology, ICAR-NIVEDI, Molecular Diagnostics, Disease Surveillance, Veterinary Epidemiology, Viral Diseases, Scopus Researcher, Research Impact, Infectious Disease Research, Animal Health, Epidemiology, Scientific Publications, International Top Pharmaceutical Awards.

Introduction

Virology remains one of the most significant scientific disciplines supporting animal health, public health preparedness, and disease prevention. Advances in molecular biology, diagnostic technologies, and epidemiological surveillance have substantially improved the detection and control of emerging infectious diseases. Researchers working within veterinary virology contribute not only to livestock health but also to broader One Health initiatives that recognize the interconnected relationship between humans, animals, and environmental health.[2]

Research Profile

Sudeep Nagaraj is affiliated with ICAR-NIVEDI, India, where his research activities focus on veterinary virology, molecular diagnostics, infectious disease surveillance, and epidemiological investigations. According to publicly available Scopus author metrics, the researcher has authored ten indexed publications, received eighty-one scholarly citations, and achieved an h-index of five. These bibliometric indicators reflect consistent scientific productivity and measurable academic visibility within the international research community. His research portfolio emphasizes interdisciplinary collaboration and contributes to the advancement of laboratory diagnostics and disease monitoring frameworks relevant to veterinary medicine.[1]

Research Contributions

The research contributions of Sudeep Nagaraj primarily address the understanding, diagnosis, surveillance, and epidemiology of viral diseases affecting livestock and animal populations. His work has supported improvements in molecular diagnostic techniques, pathogen detection strategies, and laboratory investigations that strengthen veterinary disease management. Through collaborative research, he has contributed to scientific evidence used in monitoring emerging and re-emerging infectious diseases while promoting reliable diagnostic methodologies applicable to veterinary public health.[2]

Publications

The research publication portfolio of Sudeep Nagaraj consists of peer-reviewed scientific articles indexed in internationally recognized databases. These publications collectively focus on veterinary virology, infectious disease surveillance, molecular diagnostics, epidemiology, and laboratory investigations. The studies have contributed to scientific understanding of viral pathogens affecting livestock and have supported advancements in disease monitoring and diagnostic methodologies.[1]

Research Impact

Bibliometric indicators available through Scopus demonstrate measurable scholarly visibility for Sudeep Nagaraj. With ten indexed publications, eighty-one citations, and an h-index of five, the available metrics indicate sustained academic engagement and continuing influence within veterinary virology research. Citation performance suggests that his published work has contributed to ongoing scientific discussions related to infectious diseases, diagnostic technologies, and epidemiological surveillance.[1]

Award Suitability

The Excellence in Research Award recognizes researchers demonstrating scientific quality, sustained scholarly productivity, measurable research impact, and meaningful contributions to their respective disciplines. Based on publicly available bibliometric indicators, indexed publications, citation performance, and continued engagement in veterinary virology research, Sudeep Nagaraj demonstrates characteristics that are consistent with the objectives of the International Top Pharmaceutical Awards. His contributions to infectious disease research, molecular diagnostics, and veterinary epidemiology reflect an active commitment to advancing scientific knowledge and supporting evidence-based healthcare practices.[1][5]

Conclusion

Sudeep Nagaraj has established a consistent academic profile through contributions to veterinary virology, molecular diagnostics, infectious disease surveillance, and epidemiological research. His publication record, citation metrics, and collaborative scientific activities demonstrate continued engagement with internationally recognized research. The available evidence supports recognition of his scholarly achievements and highlights the significance of his work in advancing veterinary science, disease monitoring, and animal health research. Continued scientific contributions are expected to further strengthen the impact of his research within the global academic community.[1][2]

References

  1. Elsevier. (n.d.). Scopus Author Profile: Sudeep Nagaraj (Author ID: 58639369200). Scopus. https://www.scopus.com/pages/search/authors?firstName=Sudeep&lastName=Nagaraj
  2. Bayyappa, M. R. G., Nagaraj, S., Bijalwan, S., Basavarajappa, C. K. H., Shivachandra, S. B., & Gulati, B. R. (2026). Development and Validation of a Population Assay for the Seroprevalence of Lumpy Skin Disease. Microorganisms. https://doi.org/10.3390/microorganisms14020373
  3. Bayyappa, M. R. G., Pabbineedi, S. M., Nagaraj, S., Bijalwan, S., Tadakod, S., Uma, C. R., Pawar, S., Khan, P. Y., Teotia, V. K., & Gulati, B. R. (2025). Spatiotemporal Epidemiology of Lumpy Skin Disease and Evaluation of the Heterologous Goatpox Vaccine: Insights into Immunogenicity and Impact. Vaccines. https://doi.org/10.3390/vaccines13060641
  4. Manjunatha Reddy, G. B., Sudeep, N., Rizwan, A., Sumana, K., Pabbineedi, S. M., Yogisharadhya, R., Balamurugan, V., Rajeswari, S., & Shivachandra, S. B. (2025). Development and validation of recombinant A27L based indirect-ELISA for Sheeppox and Goatpox disease in India. Veterinary Research Communications. https://doi.org/10.1007/s11259-025-10656-5
  5. Manjunatha Reddy, G. B., Bijalwan, S., Jacob, S. S., Tadakod, S., Maharana, S. M., Nagaraj, S., Pabbineedi, S. M., Uma, C. R., Balappa, V. P., et al. (2025). Investigation of Comorbidity and Risk Factors Analysis During Lumpy Skin Disease Outbreaks in India. Microorganisms. https://doi.org/10.3390/microorganisms13030472

Mohamed Mahmoud Marey | Internal Medicine | Young Researcher Award

Published on by Top Pharmaceutical

Young Researcher Award

Mohamed Mahmoud Marey
Affiliation Alexandria University
Country Egypt
Scopus ID 59729417400
Documents 33
Citations 25
h-index 3
Subject Area Internal Medicine
Event International Top Pharmaceutical Awards
Google Scholar View Profile

Mohamed Mahmoud Marey  – Alexandria University

Mohamed Mahmoud Marey is a researcher affiliated with Alexandria University, Egypt, whose scholarly activities are centered on Internal Medicine and related clinical research. His academic record demonstrates continuing participation in medical research through peer-reviewed publications indexed by internationally recognized databases, reflecting sustained engagement with evidence-based healthcare and scientific communication. The Young Researcher Award presented through the International Top Pharmaceutical Awards recognizes promising investigators who have demonstrated scholarly productivity, research integrity, and continued commitment to advancing biomedical knowledge.[4]

Abstract

This academic profile summarizes the research activities and scholarly achievements of Mohamed Mahmoud Marey in the field of Internal Medicine. Available bibliometric indicators show active publication within internationally indexed journals and continuing participation in clinical and medical research. The profile highlights publication performance, research visibility, scientific impact, and professional recognition in relation to the objectives of the Young Researcher Award while maintaining a neutral academic perspective supported by publicly available scholarly resources.[1][2]

Keywords

Young Researcher Award, Mohamed Mahmoud Marey, Alexandria University, Internal Medicine, Clinical Research, Pharmaceutical Research, Medical Innovation, Evidence-Based Medicine, Scientific Publications, Healthcare Research, Scopus Author, Google Scholar, Biomedical Science, International Top Pharmaceutical Awards.

Introduction

Internal Medicine represents a broad scientific discipline that integrates clinical observation, biomedical investigation, and evidence-based therapeutic practices to improve patient care. Researchers working within this area contribute to disease prevention, diagnosis, treatment optimization, and translational medicine through systematic scientific inquiry. International collaboration and publication within indexed journals remain essential indicators of research quality and academic visibility, enabling scientific findings to influence healthcare practice across diverse populations.[2]

Research Profile

According to publicly accessible scholarly indexing records, Mohamed Mahmoud Marey has authored thirty-three indexed research documents and accumulated twenty-five citations, resulting in an h-index of three. These bibliometric indicators represent measurable academic productivity and demonstrate ongoing participation in scientific publishing within Internal Medicine and related healthcare disciplines. The available publication record reflects continued engagement with peer-reviewed research while contributing to the broader dissemination of medical knowledge through internationally recognized indexing platforms.[1][2]

Research Contributions

Mohamed Mahmoud Marey’s research contributions primarily focus on Internal Medicine through studies that support improved clinical practice, patient management, and evidence-based healthcare. His publications address medically relevant topics by applying scientific methodologies that contribute to the understanding of disease mechanisms, diagnostic strategies, and therapeutic interventions. These investigations demonstrate continued engagement with contemporary clinical challenges while promoting reliable scientific evidence for healthcare professionals.[2]

Publications

The researcher’s publication portfolio comprises peer-reviewed articles published in internationally recognized journals and indexed in major academic databases. His scholarly work primarily focuses on Internal Medicine, gastroenterology, hepatology, evidence-based medicine, and systematic reviews with meta-analyses. The published studies demonstrate consistent scientific productivity through collaborative research addressing clinically significant healthcare challenges while supporting advances in patient care and medical decision-making. Collectively, these publications reflect an active commitment to high-quality biomedical research, international scientific collaboration, and the dissemination of reliable evidence that contributes to the continued development of clinical practice and pharmaceutical sciences.[1][2]

Research Impact

Bibliometric indicators provide measurable evidence of academic influence by reflecting publication output, citation activity, and scholarly visibility. Based on publicly available indexing records, Mohamed Mahmoud Marey has produced thirty-three indexed publications, received twenty-five citations, and achieved an h-index of three. These indicators demonstrate sustained research activity and continuing participation in scientific communication within Internal Medicine.[1]

Award Suitability

The Young Researcher Award recognizes investigators who demonstrate promising academic development through quality research, scholarly publications, and continued professional engagement. Based on the available bibliometric indicators, publication history, and international indexing presence, Mohamed Mahmoud Marey demonstrates characteristics that align with the objectives of the International Top Pharmaceutical Awards. His documented research productivity and contribution to medical science support consideration within a competitive academic recognition framework while maintaining a neutral and evidence-based assessment.[1]

Conclusion

Mohamed Mahmoud Marey’s academic profile reflects continued participation in Internal Medicine research through peer-reviewed publications, internationally indexed scholarly output, and measurable bibliometric performance. His publication record, citation metrics, and ongoing research engagement illustrate sustained commitment to scientific advancement and responsible academic communication. Collectively, these achievements represent a foundation consistent with the principles recognized by international research award programs.[1]

References

    1. Marey, M. M., Belal, M., Awad, A. A., Rabea, E. M., Hassan, M. A., Abbas, A. W., & Nashwan, A. J. (2024). Efficacy and safety of aldafermin in non-alcoholic steatohepatitis: A systematic review and meta-analysis of randomized controlled trials. Clinics and Research in Hepatology and Gastroenterology, 48(6), 102357. https://doi.org/10.1016/j.clinre.2024.102357
    2. Awad, A. A., Abosheaishaa, H., Hassan, M. A., Marey, M. M., Bahnasy, A., et al. (2025). Endoscopic Submucosal Dissection with Rubber Bands and Clips Compared to Conventional Endoscopic Submucosal Dissection: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences, 70(8), 2823–2833. https://doi.org/10.1007/s10620-025-09074-z
    3. Marey, M. M., Alkilani, F., Genidy, A. M., Mahmood, J., Adel, M., & Elhady, M. M. (2025). Thyroid Hormone Receptor Beta (THRβ) Agonists in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Bridging the Gap Between Promise and Practice. Journal of Gastrointestinal and Liver Diseases, 34(4).https://pubmed.ncbi.nlm.nih.gov/41453099/
    4. Marey, M. M., Awad, A. A., Genidy, A. M., Abdelaziz, A. B., Aboelkhier, M. M., Hassan, M. A., & colleagues. (2026). Efficacy and safety of hand suturing technique application in the endoscopic treatment of gastrointestinal tract tumors: A systematic review and meta-analysis. European Surgery, 58(1), 2–12.https://link.springer.com/article/10.1007/s10353-025-00887-w

May Abdullah Almoshary | Hematology | Innovative Research Award

Published on by Top Pharmaceutical

Innovative Research Award

May Abdullah Almoshary
Princess Nourah Bint Abdulrahman University, Saudi Arabia
May Abdullah Almoshary
Affiliation Princess Nourah Bint Abdulrahman University
Country Saudi Arabia
Scopus ID 57193323753
Documents 11
Citations 103
h-index 5
Subject Area Hematology
Event International Top Pharmaceutical Awards
ORCID 0000-0003-4839-5032

The Innovative Research Award recognizes distinguished scholarly achievement, sustained scientific productivity, and meaningful contributions to academic advancement within specialized research disciplines. This article presents a structured overview of the academic profile of May Abdullah Almoshary, whose published work in hematology demonstrates continuous engagement in clinical investigation, evidence-based practice, and interdisciplinary collaboration. The available bibliometric indicators and internationally indexed publications provide an objective basis for evaluating research visibility and scholarly influence within the biomedical sciences.[1]

Abstract

May Abdullah Almoshary has established an academic profile characterized by sustained research activity in hematology and related biomedical disciplines. Her scholarly work reflects a commitment to improving scientific understanding through clinical investigation, collaborative research, and publication in internationally indexed journals. Citation performance, publication metrics, and institutional affiliation collectively indicate continued engagement with contemporary medical research and knowledge dissemination. The Innovative Research Award acknowledges researchers whose scientific contributions demonstrate originality, measurable impact, and ongoing professional development. .[2]

Keywords

Innovative Research Award, Hematology, Clinical Research, Biomedical Science, Princess Nourah Bint Abdulrahman University, Scopus, Scientific Publications, Medical Research, Research Excellence, International Top Pharmaceutical Awards.

Introduction

Recognition through international academic awards emphasizes research quality, scientific integrity, and measurable scholarly contribution. Modern evaluation frameworks frequently incorporate publication productivity, citation performance, collaborative engagement, and research relevance when assessing candidates for research recognition. Bibliometric databases further provide transparent indicators that assist institutions and professional organizations in identifying researchers whose work demonstrates sustained academic influence.[1]

Research Profile

May Abdullah Almoshary is affiliated with Princess Nourah Bint Abdulrahman University in Saudi Arabia and has developed an active research portfolio within hematology. According to publicly available Scopus indexing records, the researcher has authored eleven indexed publications, accumulated more than one hundred citations, and achieved an h-index of five. These indicators reflect continued participation in internationally visible scientific research while demonstrating consistent academic productivity and citation impact across published work. Her publications illustrate participation in collaborative biomedical investigations addressing clinically significant topics relevant to hematological disorders, laboratory diagnostics, and patient-centered healthcare. [2]

Research Contributions

The research contributions of May Abdullah Almoshary are centered on advancing knowledge in hematology through clinical investigations, collaborative biomedical research, and evidence-based scientific reporting. Her studies address topics that support improved understanding of blood disorders, laboratory medicine, patient management, and translational healthcare. The integration of clinical observations with modern research methodologies has strengthened the practical relevance of her published work while contributing to the growing body of international hematology literature.[2]

Publications

The publication record reflects sustained scholarly engagement in hematology and related biomedical sciences through peer-reviewed academic journals. The published studies address clinically relevant topics, contribute to scientific understanding, and support evidence-based healthcare practices across diverse medical settings. The research demonstrates consistent collaboration with national and international scholars while emphasizing methodological quality, scientific integrity, and practical clinical relevance. Collectively, these publications strengthen academic visibility, encourage interdisciplinary knowledge exchange, and provide valuable scientific evidence that supports future investigations and continued advancement within the field of hematology.[1][2]

Research Impact

Bibliometric indicators provide measurable evidence of scholarly influence and research visibility. According to publicly available Scopus records, May Abdullah Almoshary has produced eleven indexed publications, received more than one hundred citations, and achieved an h-index of five. These metrics demonstrate that her work has been recognized and referenced within the international scientific community while reflecting sustained academic engagement in hematology research.Continued citation activity indicates the ongoing relevance of her research within biomedical science and supports the dissemination of reliable clinical knowledge across international academic networks.[2]

Award Suitability

The Innovative Research Award recognizes originality, scientific quality, measurable research impact, and sustained scholarly excellence. Based on the available publication record, bibliometric indicators, international indexing, and continued contribution to hematology research, May Abdullah Almoshary demonstrates characteristics consistent with the objectives of the International Top Pharmaceutical Awards. Her research profile reflects scientific integrity, collaborative engagement, and continued commitment to advancing biomedical knowledge through peer-reviewed investigation.[1][2]

Conclusion

The academic achievements of May Abdullah Almoshary illustrate a sustained commitment to scientific excellence within hematology and biomedical research. Through internationally indexed publications, measurable citation impact, and collaborative scientific activity, the researcher has contributed to the advancement of evidence-based medical knowledge. These accomplishments align with internationally recognized standards for academic distinction and support consideration for professional research recognition through the Innovative Research Award.

References

  1. Elsevier. (n.d.). Scopus Author Details: May Abdullah Almoshary (Author ID: 57193323753). Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57193323753
  2. AlMoshary, M. (2026). Living with sickle cell disease in the Arab world: Quality of life beyond clinical severity. Blood Cells, Molecules, and Diseases.
    https://doi.org/10.1016/j.bcmd.2026.103026
  3. AlMoshary, M., et al. (2024). The role of prophylactic transfusion on the maternal and fetal outcomes in pregnant women with sickle cell disease: A systematic review and meta-analysis. Medicine.
    https://doi.org/10.1097/MD.0000000000039475
  4. Bakhsh, E., Shaban, M., Al Subaie, S., Al Moshary, M., & AlSheef, M. (2023). Exploring the Clinical Efficacy of Venous Thromboembolism Management in Saudi Arabian Hospitals: An Insight into Patient Outcomes. Journal of Personalized Medicine, 13(4).
    https://www.mdpi.com/2075-4426/13/4/612
  5. Bakr, S., AlFattani, A., Al-Nounou, R., et al. (2022). Hematologic reference intervals for healthy adult Saudis. Annals of Saudi Medicine, 42.
    https://doi.org/10.5144/0256-4947.2022.191